Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance

Clin Exp Immunol. 2017 May;188(2):219-225. doi: 10.1111/cei.12931. Epub 2017 Mar 2.

Abstract

Anti-apoptotic genes, including those of the Bcl-2 family, have been shown to have dual functionality inasmuch as they inhibit cell death but also regulate inflammation. Several anti-apoptotic molecules have been associated with endothelial cell (EC) survival following transplantation; however, their exact role has yet to be elucidated in respect to controlling inflammation. In this study we created mice expressing murine A1 (Bfl-1), a Bcl-2 family member, under the control of the human intercellular adhesion molecule 2 (ICAM-2) promoter. Constitutive expression of A1 in murine vascular ECs conferred protection from cell death induced by the proinflammatory cytokine tumour necrosis factor (TNF)-α. Importantly, in a mouse model of heart allograft transplantation, expression of A1 in vascular endothelium increased survival in the absence of CD8+ T cells. Better graft outcome in mice receiving an A1 transgenic heart correlated with a reduced immune infiltration, which may be related to increased EC survival and reduced expression of adhesion molecules on ECs. In conclusion, constitutive expression of the anti-apoptotic molecule Bfl1 (A1) in murine vascular ECs leads to prolonged allograft survival due to modifying inflammation.

Keywords: anti-apoptotic; endothelial.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / genetics
  • Apoptosis
  • CD8-Positive T-Lymphocytes
  • Cell Adhesion Molecules / genetics
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / immunology
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / cytology
  • Gene Expression*
  • Graft Survival
  • Heart Transplantation*
  • Humans
  • Inflammation
  • Mice
  • Minor Histocompatibility Antigens / genetics*
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • Transplantation Tolerance*
  • Transplantation, Homologous
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antigens, CD
  • BCL2-related protein A1
  • Cell Adhesion Molecules
  • ICAM2 protein, human
  • Minor Histocompatibility Antigens
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Necrosis Factor-alpha